Clinical trial
Study of Cetuximab With and Without Weekly Paclitaxel for Patients With…
NCT00350025 · Fox Chase Cancer Center, Other · Completed
Key facts
| NCT number | NCT00350025 |
|---|---|
| Title | Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer |
| Official title | Randomized Phase II Trial of Cetuximab With and Without Weekly Paclitaxel in Patients With Previously Treated Advanced Urothelial Cancer |
| Lead sponsor | Fox Chase Cancer Center, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Urologic Neoplasm |
| Intervention type | Drug |
| Interventions | Cetuximab, Paclitaxel |
| Enrollment | 41 |
| Start date | Aug 1, 2006 |
| Primary completion | Jul 1, 2010 |
| Completion | Sep 1, 2012 |
| First posted | Jul 10, 2006 |
| Last update posted | Mar 31, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: